Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Direskeneli

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
The Journal of Rheumatology|May 6, 1999
Phenotypic characteristics of B cells in Behçet's disease: increased activity in B cell subsetsE Ekşioglu-Demiralp, A Kibaroglu, H Direskeneli, et al.
Journal of the American Academy of Dermatology|November 17, 2001
HSP 60 expression in mucocutaneous lesions of Behçet's diseaseT Ergun, U Ince, E Ekşioğlu-Demiralp, et al.
The Journal of Rheumatology|June 1, 1994
Systemic interferon alpha 2b treatment in Behçet's syndromeV Hamuryudan, F Moral, S Yurdakul, et al.
Scandinavian Journal of Immunology|April 1, 1996
Recognition of B-cell epitopes of the 65 kDa HSP in Behçet's diseaseH Direskeneli, A Hasan, T Shinnick, et al.
Acta Neurologica Scandinavica|June 1, 1996
Antibodies against endothelial cells in patients with multiple sclerosisM Tintore, A L Fernandez, A Rovira, et al.
British Journal of Rheumatology|December 16, 1998
Skin hyperreactivity of Behçet's patients (pathergy reaction) is also positive in interferon alpha-treated chronic myeloid leukaemia patients, indicating similarly altered neutrophil functions in both disordersT Budak-Alpdogan, Demirçay, O Alpdogan, et al.
Oral Diseases|February 16, 2006
Oral health related quality of life is affected by disease activity in Behçet's diseaseG Mumcu, N Inanc, T Ergun, et al.
Clinical and Experimental Rheumatology|February 1, 2014
Ankylosing spondylitis and a diagnostic dilemma: coccydyniaR Deniz, G Ozen, S Yilmaz-Oner, et al.
Clinical Rheumatology|January 1, 1995
Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's diseaseH Direskeneli, G Keser, D D'Cruz, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|March 21, 2009
Oral health and related quality of life status in patients from UK and Turkey: a comparative study in Behcet's diseaseG Mumcu, S Niazi, J Stewart, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
The Journal of Rheumatology|May 6, 1999
Phenotypic characteristics of B cells in Behçet's disease: increased activity in B cell subsetsE Ekşioglu-Demiralp, A Kibaroglu, H Direskeneli, et al.
Journal of the American Academy of Dermatology|November 17, 2001
HSP 60 expression in mucocutaneous lesions of Behçet's diseaseT Ergun, U Ince, E Ekşioğlu-Demiralp, et al.
The Journal of Rheumatology|June 1, 1994
Systemic interferon alpha 2b treatment in Behçet's syndromeV Hamuryudan, F Moral, S Yurdakul, et al.
Scandinavian Journal of Immunology|April 1, 1996
Recognition of B-cell epitopes of the 65 kDa HSP in Behçet's diseaseH Direskeneli, A Hasan, T Shinnick, et al.
Acta Neurologica Scandinavica|June 1, 1996
Antibodies against endothelial cells in patients with multiple sclerosisM Tintore, A L Fernandez, A Rovira, et al.
British Journal of Rheumatology|December 16, 1998
Skin hyperreactivity of Behçet's patients (pathergy reaction) is also positive in interferon alpha-treated chronic myeloid leukaemia patients, indicating similarly altered neutrophil functions in both disordersT Budak-Alpdogan, Demirçay, O Alpdogan, et al.
Oral Diseases|February 16, 2006
Oral health related quality of life is affected by disease activity in Behçet's diseaseG Mumcu, N Inanc, T Ergun, et al.
Clinical and Experimental Rheumatology|February 1, 2014
Ankylosing spondylitis and a diagnostic dilemma: coccydyniaR Deniz, G Ozen, S Yilmaz-Oner, et al.
Clinical Rheumatology|January 1, 1995
Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's diseaseH Direskeneli, G Keser, D D'Cruz, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|March 21, 2009
Oral health and related quality of life status in patients from UK and Turkey: a comparative study in Behcet's diseaseG Mumcu, S Niazi, J Stewart, et al.
Pageof 10